Stocks股票 / Health Care / GILD

Gilead Sciences · Health Care

GILD US listed · USD美股 · 美元

Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19.吉利德科学公司是一家美国生物制药公司,总部位于加利福尼亚州福斯特城,专注于研发用于治疗HIV/AIDS、乙型肝炎、丙型肝炎、流感和COVID-19的抗病毒药物。

Large cap大盘 · $187B Health Care Rate-sensitive利率敏感
$150.93
+$1.24 · +0.83%
52w low52周低 $106high高 $155
Neutral — no clear edge中性 — 无明显优势 Trend intact — hold; add on dips toward the 10-day average.趋势完好——持有;可在回调至 10 日均线附近时加仓。 As of 2026-09-28截至 2026-09-28
Company intelligence公司情报

The latest call, in context把最新财报放回历史脉络

A synthesized event record across management commentary and recorded metrics. Read as context; verify exact wording in the transcript before relying.综合管理层表述与记录指标形成事件档案。仅供参考;使用前请在电话会原文中核对准确措辞。

Checking latest record正在检查最新记录

Live company record实时公司记录

JavaScript loads the source-bounded event record here. Open Terminal if the live module does not start.JavaScript 会在此加载受来源约束的事件记录。如实时模块未启动,请打开终端。

Continue with full transcript history继续查看完整电话会历史 ↗

Price chart价格图表

daily · interactive日线 · 可交互 Open in Terminal打开终端 ↗
Loading chart…图表加载中…
The interactive chart could not load here.互动图表暂时无法在此加载。 Open the live chart in Terminal在终端中打开实时图表 ↗
Candles, volume and moving averages — pan and zoom inside the chart.蜡烛图、成交量与均线 — 图内可缩放拖动。 MMastermind Terminal — live & interactiveMastermind 终端 — 实时互动 ↗

Technicals技术面

daily bars日线数据 · 2026-09-28
MA Buy (7)Short-term Rising TrendLong-term Rising Trend
Momentum (RSI 14)动量(RSI 14) 61
Elevated偏高
vs 50-day average相对50日均线 +7.2% above上方 Uptrend intact趋势完好
vs 200-day average相对200日均线 +12.3% above上方 Long trend up长期向上
Trend strength (ADX)趋势强度(ADX) 32 Strong trend趋势强劲
Volatility波动率 19th percentile第19百分位
These readings feed the stance at the top — one source per number, refreshed nightly.以上读数构成页首的引擎立场 — 每个数字只有一个来源,每晚更新。

Earnings财务业绩

next report下次财报 2026-10-29
31
days to go天后公布

Estimates roughly stable预期基本稳定

Beat expectations 4 quarters in a row连续 4 季度超预期

+4.5% Jun 2026
+7.4% Mar 2026
+1.6% Dec 2025
+14.9% Sep 2025

EPS surprise vs consensus, last quarters每股收益相对预期的超预期幅度(近几个季度) · average平均 7.1%

Valuation估值

Roughly fair vs sector相对行业估值合理
Multiple指标GILD Sector median行业中位Cheaper than相对便宜
P/E (trailing)市盈率(历史) 22.01x 29.58 69%
P/E (forward)市盈率(预测) 15.3x — —
P/B市净率 8.25x 3.30 17%
P/S市销率 6.36x 3.19 25%
Earnings yield盈利收益率 4.54% 2.56 78%
FCF yield自由现金流收益率 5.05% 4.11 66%
Shareholder yield股东收益率 1.03% 1.87 32%
EV/EBITDA企业价值/EBITDA 19.70x 18.26 44%
P/FCF市值/自由现金流 19.81x 21.34 60%
"Cheaper than" = share of sector peers trading richer on that multiple.「相对便宜」= 行业中该指标估值更高的同行占比。

Financials财务数据

fiscal years财年
Revenue营业收入 $29.4B2025
20202025
5-yr growth5年复合增速 3.6%
Earnings per share每股收益 $6.782025
20202025
5-yr growth5年复合增速 132.4%
Free cash flow自由现金流 $9.5B2025
20202025
Operating margin营业利润率
34.0%
Net margin净利率
28.9%
FCF margin自由现金流利润率
34.0%
Balance-sheet quality财务体质 7/9 Bankruptcy risk: safe zone破产风险:安全区 Return on equity股本回报率 38% Clean稳健

Leverage杠杆

Net debt / EBITDA净债务/EBITDA1.67
Current ratio流动比率1.55

Capital allocation资本配置

Buybacks (TTM)回购(TTM)$1.9B
Stock-based comp股权薪酬$894.0M
Share count change (1y)股数变化(1年)-0.4%

Debt coming due到期债务

FY2020 10-K

In the 12-month bucket following fiscal period end 2020-12-31, it reported $2.8B due — about 9% of its disclosed principal.在财年期末 2020-12-31 之后12个月的区间内,已披露到期本金为 $2.8B,约占其披露本金的 9%。

All maturity buckets are measured from fiscal period end 2020-12-31, not from today.所有到期区间均从财年期末 2020-12-31 起算,而非从今天起算。

First 12 months after period end报告期末之后首12个月 $2.8B
Year 2第2年 $1.5B
Year 3第3年 $4.2B
Year 4第4年 $1.8B
Year 5第5年 $1.8B
After year 55年以后 $18.5B

A cash-flow scenario is unavailable until the filing inputs are verified.报告数据核实前,现金流情景暂不可用。

Capital-need coverage is partial; incomplete or incompatible filing inputs are not combined.资本需求覆盖信息不完整;不会合并不完整或不兼容的报告数据。

Any available cash-flow scenario is context only. Missing or incompatible inputs are not replaced with zero or a financing forecast.可用现金流情景仅供参考;缺失或不兼容的输入不以零值或融资预测替代。

Sources and cash-flow calculation来源与现金流计算

Figures are XBRL facts from one filing — no two years are mixed. Filing数据取自同一份文件中的 XBRL 事实,不跨文件拼接。文件 0000882095-21-000008, period ending报告期截至 2020-12-31, unit单位 USD. Cache acquired缓存获取时间: 2026-09-25T08:20:54.228492+00:00. 6/6 buckets reported.个区间有披露。

  • LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
  • LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
  • LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
  • LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
  • LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
  • LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
Research context only — reported figures from SEC filings, not a rating, a signal or investment advice.仅供研究参考 — 数据摘自 SEC 文件披露口径,不构成评级、信号或投资建议。

Why is it moving为何波动

6 checks · nightly六项检查 · 每晚
Sector / Theme行业/主题 Big Pharma theme — #8 of 49 themes「大型药企」主题 — 49 个主题中第 8 位
Macro宏观 Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓 Short interest changed -20.4%空头仓位变动 -20.4%
Technical技术面 BOTTOMING → NEARING A HIGH筑底中 → 接近高点

Options positioning期权持仓

as of last close截至上一收盘

Market makers are net long gamma — price pinned near current level做市商净持有正伽玛,价格倾向于在当前水平附近震荡

Expected daily move预期日波动
±1.83%
Expected weekly move预期周波动
±4.09%
Gamma flip伽玛翻转位
$119
25d risk reversal25d风险逆转
-2.6%
Skew: balanced偏斜:balanced
Call and put walls are plotted on the Trade levels ladder →看涨/看跌期权墙已标注在「交易点位」阶梯上 →

Ownership & smart money持仓与聪明钱

13F

Insider activity:内部人动向: -$53.1M net (0 buyers, 4 sellers)-$53.1M 净值(0 买家,4 卖家)

Signal history信号历史

engine events引擎事件
NEARING A HIGH → UPTREND接近高点 → 上涨趋势 HOLD. Day 10 of the cycle, trend intact above a rising 10-day average, weekly still mixed持有。周期第 10 天,趋势完好并位于向上的 10 日均线之上,周线仍为混合
Sep 24, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Sep 24, 2026
GILD daily MACD crossed downGILD 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $149.69.日线MACD柱状图转负 — 快速且嘈杂,仅作背景。$149.69。
Sep 23, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Sep 22, 2026
GILD daily MACD crossed upGILD 日线MACD上穿
The daily MACD histogram turned positive — fast and noisy, context rather than a standalone trigger. $152.67.日线MACD柱状图转正 — 快速且嘈杂,仅作背景。$152.67。
Sep 17, 2026
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP买入预备
Sep 16, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Sep 15, 2026
GILD StochRSI turned up from oversoldGILD StochRSI自超卖区上行
StochRSI popped back above 20 — the earliest oscillator heads-up that downside momentum is easing. $146.30.StochRSI重回20上方 — 下行动量趋缓的最早预警。$146.30。
Sep 14, 2026
GILD took relative-strength leadershipGILD 取得相对强弱领先
Relative strength vs SPY crossed above the 90th percentile of the last 90 days — leadership tends to persist. $145.59.相对标普500的强弱上穿近90日的第90百分位 — 领先往往延续。$145.59。
Showing the last 15 of显示最近15条,共 3123 signals条信号

Company profile公司档案

Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19.吉利德科学公司是一家美国生物制药公司,总部位于加利福尼亚州福斯特城,专注于研发用于治疗HIV/AIDS、乙型肝炎、丙型肝炎、流感和COVID-19的抗病毒药物。

Style DNA — how it trades vs the market风格基因 — 相对市场的交易特征
Value价值
Below market低于市场
Quality质量
Below market低于市场
Investment资本投入
Above market高于市场
Shareholder payout股东回报
Below market低于市场
Low volatility低波动
Above market高于市场
Low market beta低市场敏感度
Above market高于市场
Earnings quality盈利质量
Below market低于市场
Short interest空头兴趣
Below market低于市场

AI research briefAI研究简报

generated生成于 2026-09-21

GILD is showing a partial bottoming/buy-setup signal: a short-term swing low formed in August, price is back above its 10-day average and near its 52-week high, but the weekly timeframe has not turned and macro liquidity is a headwind. Fundamentals look strong on margin, ROE and cash flow, while factor tilts are mixed and the composite is slightly negative.

GILD正显示部分触底/买入布局信号:8月形成短期波段低点,价格重回10日均线上方并接近52周高点,但周线周期尚未转向,宏观流动性构成逆风。基本面在利润率、ROE和现金流方面看起来强劲,而因子暴露好坏参半,综合得分略为负值。

Key drivers主要驱动
  • Short-term cycle/ladder signal: new swing low 2026-08-17 at 138.14, price back above 10-day average, daily momentum near turning up
  • Price trend: above 50-day and 200-day MAs, +12.5% vs 200dma, only -1.6% from 52-week high, RSI14 63
  • Factor tilts: favorable low-vol, low-beta and short-interest; unfavorable value, quality and payout
  • Fundamentals: 28.9% net margin, 37.5% ROE, net income growth 1,672.9%, CFO $10.0B, buybacks $1.9B
  • Seasonality: September historically +3.4% average, up 60% of years
Key risks主要风险
  • Weekly timeframe has not turned; bigger-picture trend is mixed with no clear daily trend
  • Macro headwind: US net liquidity contracting
  • Factor composite is slightly negative at -0.129, with weak value and quality tilts
  • MACD remains negative despite price strength
  • Late investor cycle phase and price close to 52-week high could limit upside
  • High long-term debt of $22.1B
Upcoming catalysts近期催化剂
  • Watch whether the daily momentum turn is followed by a weekly trend turn
  • October seasonality is softer: +0.3% average, up 53% of years
  • Macro liquidity developments
  • No company-specific earnings or product catalyst provided
Research context only — not a signal, not advice. This is an AI-generated reading of one stock's PUBLIC, already-computed context (its cycle/technical state, cross-sectional factor scores, SEC fundamentals, and recent public news). It does NOT feed any score, signal, ladder call or position size, and it can be wrong or overconfident. The mechanical engine never sees it. Verify every claim against the deterministic analysis on the same page. No holdings or watchlist information is used.

The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。

Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。

Browse all stocks浏览所有股票 Open Terminal打开终端

Research context only — not investment advice. Past patterns do not guarantee future results.仅供研究参考,不构成投资建议。历史规律不代表未来表现。

Data through数据截至 2026-09-28 · regenerated nightly每晚更新 · Generated生成于 2026-09-29 04:25 UTC · All coverage所有股票 · Analyzer分析器